The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.
The FDA Fast-Tracks Its Review of Psilocybin and Methylone, 2 Promising Psychedelics
The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.
